Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy

Personalised cancer treatment depends on identification of therapeutically relevant biological subgroups of patients for assessing effect of treatment and to discover new therapeutic options. By analyses in heterogeneous patient populations, the effects may be lost in noise. Squamous cell carcinoma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cancer
Autors principals: Haakensen, Vilde D., Khadse, Anand, Sandhu, Vandana, Halvorsen, Ann Rita, Solberg, Steinar K., Jørgensen, Lars H., Brustugun, Odd Terje, Kure, Elin H., Helland, Åslaug
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Tumor Markers and Signatures
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7540694/
https://ncbi.nlm.nih.gov/pubmed/32468587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33121
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars